NEW YORK (Reuters Health) – Assessing kidney function with both the estimated glomerular filtration rate (eGFR) and with urinary albumin levels can help predict whether chronic kidney disease…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
NEW YORK (Reuters Health) – By binding dietary oxalate, calcium supplements or calcium-containing foods may be useful in the management of hyperoxaluria, new research suggests. Hyperoxaluria is present…
Rasheed A. Balogun, MD, Associate Professor of Medicine in the Division of Nephrology at the University of Virginia Health System, discusses the risk factors for Chronic Kidney Disease…
James A. Underberg, MD, Clinical Assistant Professor of Medicine, Division of General Internal Medicine at NYU Medical School, discusses the interpretation of recent NHANES data relating to the…
James A. Underberg, MD, Clinical Assistant Professor of Medicine, Division of General Internal Medicine at NYU Medical School, discusses how to approach and treat a patient with elevated…
Talissa A. Altes, MD, Associate Professor of Radiology at University of Virginia Health System, discusses the use of hyperpolarized gas MRI to study asthma. References and Resources de…
NEW YORK (Reuters Health) – Diabetics who use drugs from the glitazone class appear to have a modest increase in risk of developing macular edema, according to study…
NEW YORK (Reuters Health) – Surgically induced weight loss is cost-effective relative to conventional therapy for the management of type 2 diabetes in obese patients, both in the…
NEW YORK (Reuters Health) – Dietary counseling and food fortification can improve symptoms and general health status for patients with chronic obstructive pulmonary disease (COPD) who are at…
